MarketScreener Strategies NFL Biosciences

Stocks

Real-time Euronext Paris Other stock markets 18:08:23 31/07/2026 +03			5-day change	1st Jan Change
0.8660 ^EUR	+2.24%		+4.34%	-26.49%

07-28	NFL Biosciences Submits Application For Authorization Of The Phase 2 Tonic Clinical Trial Evaluating NFL-102 In Smoking Cessation	CI
07-07	Nfl Biosciences Presents Three Scientific Communications on Nfl-101 and Nfl-102 At 2026 Srnt-Europe Conference	CI